Association of Type 2 Diabetes With Colorectal Cancer Risk and Survival by Tumor Immunity Status

1. T2D linked to increased CRC risk and poor survival.

2. Study included 1,889 CRC cases without T2D.

3. Tumor immune status defined by immune cell scores.

4. Significant findings for low immune infiltration.

5. T2D patients showed increased all-cause mortality.

6. Emphasis on precision prevention strategies required.

7. Study led by Michael Hoffmeister, PhD.